AbbVie Inc. vs ProPhase Labs, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- AbbVie Inc. is the larger company by market value: $514.0 B against $87 M for ProPhase Labs, Inc., 5908 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Jan 5, 2024 for ProPhase Labs, Inc.). ProPhase Labs, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
- AbbVie Inc. had more revenue: $61.2 B against $4 M for ProPhase Labs, Inc., both in the year to December 2025.
- AbbVie Inc. made a net profit of $4.2 B, while ProPhase Labs, Inc. made a net loss of $15 M.
- AbbVie Inc. keeps more of each dollar of sales: a net margin of 6.9% against -339.6% for ProPhase Labs, Inc.
- AbbVie Inc. employs more people: 57,000 against 19 at ProPhase Labs, Inc. Each employee brings in about $1,072,982 of revenue at AbbVie Inc. and $228,421 at ProPhase Labs, Inc.
- AbbVie Inc.'s revenue grew faster in its latest fiscal year: +8.6% against -35.9% for ProPhase Labs, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | AbbVie Inc. ABBV · #26 in the world | ProPhase Labs, Inc. PRPH |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 2013 | 1989 |
| Size | ||
| Market cap | $514.0 B | $87 M* |
| Revenue | $61.2 B | $4 M |
| Net income | $4.2 B▲ best | $-15 M |
| Employees | 57,000 | 19 |
| Valuation | ||
| P/E ratio | 49.7× | — |
| Price to sales | 7.8× | — |
| Free cash flow yield | 3.5% | — |
| Profitability | ||
| Gross margin | 70.2%▲ best | 31.8% |
| Operating margin | 24.6%▲ best | -415.9% |
| Net margin | 6.9%▲ best | -339.6% |
| Return on equity | — | -271.4% |
| Return on invested capital | 16.0% | — |
| Growth | ||
| Revenue growth | 8.6%▲ best | -35.9% |
| Revenue growth, 3 years a year | 1.8%▲ best | -67.2% |
| Earnings per share growth | -1.3% | — |
| Financial strength | ||
| Interest cover | 5.2×▲ best | -2.6× |
| Cash | ||
| Free cash flow margin | 29.1%▲ best | -192.2% |
| Shareholder returns | ||
| Dividend yield | 2.3% | — |
| Shareholder yield | 2.5% | — |
| Strength scores | ||
| Piotroski F-score | 8 of 9 | — |
| Altman Z-score zone | grey | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jan 2024; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, AbbVie Inc. or ProPhase Labs, Inc.?
AbbVie Inc. is the larger company by market value: $514.0 B against $87 M for ProPhase Labs, Inc., 5908 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Jan 5, 2024 for ProPhase Labs, Inc.). ProPhase Labs, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Which makes more money, AbbVie Inc. or ProPhase Labs, Inc.?
AbbVie Inc. had more revenue: $61.2 B against $4 M for ProPhase Labs, Inc., both in the year to December 2025. AbbVie Inc. made a net profit of $4.2 B, while ProPhase Labs, Inc. made a net loss of $15 M.
Which is more profitable, AbbVie Inc. or ProPhase Labs, Inc.?
AbbVie Inc. keeps more of each dollar of sales: a net margin of 6.9% against -339.6% for ProPhase Labs, Inc.
Which has more employees, AbbVie Inc. or ProPhase Labs, Inc.?
AbbVie Inc. employs more people: 57,000 against 19 at ProPhase Labs, Inc. Each employee brings in about $1,072,982 of revenue at AbbVie Inc. and $228,421 at ProPhase Labs, Inc.
Which is growing faster, AbbVie Inc. or ProPhase Labs, Inc.?
AbbVie Inc.'s revenue grew faster in its latest fiscal year: +8.6% against -35.9% for ProPhase Labs, Inc.
More about AbbVie Inc.
More about ProPhase Labs, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.